Home › Cohorts › Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria respons
Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria respons PC0B1F1273
3 studies · 125 curated samples · 54 distinct subject identifiers · 2 shared papers. Grouping rule: shared own-data paper.
Age categories
| unknown | 67 |
| child | 58 |
Countries
| CA | 125 |
Health conditions
| other_cancer Other cancer (incl. immunotherapy cohorts) | 125 |
Studies
| study | title | samples | source |
|---|---|---|---|
| PRJEB53954 | Pediatric Leukemia and Lymphoma patient stool microbiome | 67 | infant_catalog |
| PRJEB29237 | 16S rRNA gene amplicon and metagenomic shotgun sequencing reads from a pediatric acute lymphoblastic leukemia cohort. Metagenomic shotgun sequencing reads have been prefiltered to remove any human DNA before uploading to following ethical guidelines for the study. | 44 | gut_all_v1 |
| PRJEB41463 | Examining the gut microbial community and genes in children with acute lymphoblastic leukemia that experience different levels of change in serum asparaginase activity during pegaspargase treatment | 14 | gut_all_v1 |
Shared papers
- Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic defense. — PMID 35967843 · PMC9363618 · doi · studies: PRJEB29237, PRJEB41463, PRJEB46214, PRJEB53954
- The gastrointestinal antibiotic resistome in pediatric leukemia and lymphoma patients. — PMID 36909730 · PMC9998685 · doi · studies: PRJEB29237, PRJEB41463, PRJEB46214, PRJEB53954